logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo merck_oncology

ESMO 2017 : Pembrolizumab in head and neck cancer: a clinically meaningful difference and a lower toxicity in advanced forms

The treatment effect was greater in patients with PD-L1 high combined positive score.